Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sponsors Can Charge For IND Drugs If They Offer "Significant Advantage"

Executive Summary

FDA's final regulation on charging for IND drugs creates criteria for sponsors to charge for drugs other than their own during clinical trials

You may also be interested in...



Making Expanded Access Programs Work For - Not Against - Your Trial Drug

Providing an investigational drug outside of a controlled trial carries inherent development risks, but it can also be a win-win proposition for patients and sponsors when managed well, veterans of "expanded access" programs say

Making Expanded Access Programs Work For - Not Against - Your Trial Drug

Providing an investigational drug outside of a controlled trial carries inherent development risks, but it can also be a win-win proposition for patients and sponsors when managed well, veterans of "expanded access" programs say

Access To Investigational Drugs Remains Challenge Despite New FDA Rules

FDA has widely publicized ways for patients to get access to investigational trial drugs outside of trials, but there are still many barriers that could hold up implementation in the real world

Related Content

Topics

UsernamePublicRestriction

Register

LL111109

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel